The neuroproteomics of schizophrenia

Biological Psychiatry

Volumn 69, Issue 2, 2011, Pages 163-172

  English, Jane A ^a   Pennington, Kyla ^b   Dunn, Michael J ^a   Cotter, David R ^c  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c BEAUMONT HOSPITAL   (Ireland)

Author keywords

2 DE; mass spectrometry; postmortem brain; proteomics; schizophrenia

Indexed keywords

AMINO ACID SEQUENCE; BIPOLAR DISORDER; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOMICS; GLUCONEOGENESIS; GLYCOLYSIS; GRAY MATTER; HUMAN; NERVE FIBER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE; VALIDITY; WHITE MATTER;

AUTOPSY; BRAIN; BRAIN CHEMISTRY; GENE EXPRESSION PROFILING; HUMANS; NERVE TISSUE PROTEINS; NEUROPSYCHIATRY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTMORTEM CHANGES; PROTEOMICS; SCHIZOPHRENIA;

EID: 78650440703     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.06.031     Document Type: Review

References (90)

1. M.R. Wilkins, J.C. Sanchez, A.A. Gooley, R.D. Appel, I. Humphery-Smith, D.F. Hochstrasser, and K.L. Williams Progress with proteome projects: Why all proteins expressed by a genome should be identified and how to do it Biotechnol Genet Eng Rev 13 1996 19 50
2. W.H. Robinson, C. DiGennaro, W. Hueber, B.B. Haab, M. Kamachi, and E.J. Dean Autoantigen microarrays for multiplex characterization of autoantibody responses Nat Med 8 2002 295 301
3. J. Qiu, G. Choi, L. Li, H. Wang, and S.J.Pereira-Faca Pitteri Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera J Clin Oncol 26 2008 5060 5066
4. D. Jackson, R.A. Craven, R.C. Hutson, I. Graze, P. Lueth, and R.P. Tonge Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer Clin Cancer Res 13 2007 7370 7379
5. Z. Zhang, R.C. Bast Jr, Y. Yu, J. Li, L.J. Sokoll, and A.J. Rai Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res 64 2004 5882 5890
6. F. Song, A. Poljak, G.A. Smythe, and P. Sachdev Plasma biomarkers for mild cognitive impairment and Alzheimer's disease Brain Res Rev 61 2009 69 80
7. S.M. Kurian, H. Le-Niculescu, S.D. Patel, D. Bertram, J. Davis, and C. Dike Identification of blood biomarkers for psychosis using convergent functional genomics [published online ahead of print November 24] Mol Psychiatry 2009
8. A. Gorg, W. Weiss, and M.J. Dunn Current two-dimensional electrophoresis technology for proteomics Proteomics 4 2004 3665 3685
9. R. Aebersold, and D.R. Goodlett Mass spectrometry in proteomics Chem Rev 101 2001 269 295
10. B. Martin, R. Brenneman, K.G. Becker, M. Gucek, R.N. Cole, and S. Maudsley iTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: Understanding the interface between physiology and disease PLoS ONE 3 2008 e2750
11. J. Jin, G.E. Meredith, L. Chen, Y. Zhou, J. Xu, and F.S. Shie Quantitative proteomic analysis of mitochondrial proteins: Relevance to Lewy body formation and Parkinson's disease Mol Brain Res 134 2005 119 138
12. L. Choe, M. D'Ascenzo, N.R. Relkin, D. Pappin, P. Ross, and B. Williamson 8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease Proteomics 7 2007 3651 3660
13. L. Anderson, and C.L. Hunter Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol Cell Proteomics 5 2006 573 588
14. A.W. Dowsey, M.J. Dunn, and G.Z. Yang The role of bioinformatics in two-dimensional gel electrophoresis Proteomics 3 2003 1567 1596
15. R. Malik, K. Dulla, E.A. Nigg, and R. Korner From proteome lists to biological impact tools and strategies for the analysis of large MS datasets Proteomics 10 2010 1270 1283
16. P.F. Edgar, S.J. Schonberger, B. Dean, R.L. Faull, R. Kydd, and G.J. Cooper A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals Mol Psychiatry 4 1999 173 178
17. N.L. Johnston-Wilson, C.D. Sims, J.P. Hofmann, L. Anderson, A.D. Shore, E.F. Torrey, and R.H. Yolken Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder The Stanley Neuropathology Consortium Mol Psychiatry 5 2000 142 149
18. S. Prabakaran, J.E. Swatton, M.M. Ryan, S.J. Huffaker, J.T. Huang, and J.L. Griffin Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 9 2004 684 697 643
19. C.L. Beasley, K. Pennington, A. Behan, R. Wait, M.J. Dunn, and D. Cotter Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes Proteomics 6 2006 3414 3425
20. D. Clark, I. Dedova, S. Cordwell, and I. Matsumoto A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia Mol Psychiatry 11 2006 459 470 423
21. S.I. Novikova, F. He, N.J. Cutrufello, and M.S. Lidow Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis Neurobiol Dis 23 2006 61 76
22. K. Pennington, C.L. Beasley, P. Dicker, A. Fagan, J. English, and C.M. Pariante Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder Mol Psychiatry 13 2007 1102 1117
23. D. Clark, I. Dedova, S. Cordwell, and I. Matsumoto Altered proteins of the anterior cingulate cortex white matter proteome in schizophrenia Proteomics Clin Appl 1 2007 157 166
24. S. Sivagnanasundaram, B. Crossett, I. Dedova, S. Cordwell, and I. Matsumoto Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: A proteome study Proteomics Clin Appl 1 2007 1291 1305
25. A. Behan, C. Byrne, M.J. Dunn, G. Cagney, and D.R. Cotter Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression Mol Psychiatry 141 2008 601 613
26. K. Pennington, P. Dicker, M.J. Dunn, and D.R. Cotter Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia Proteomics 8 2008 5097 5107
27. J.A. English, P. Dicker, M. Focking, M.J. Dunn, and D.R. Cotter 2D-DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease Proteomics 9 2009 3368 3382
28. Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, and J.D. Buxbaum Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia Proc Natl Acad Sci U S A 98 2001 4746 4751
29. C.J. Carter EIF2B and oligodendrocyte survival: Where nature and nurture meet in bipolar disorder and schizophrenia? Schizophr Bull 33 2007 1343 1353
30. C.S. Weickert, M.J. Webster, T.M. Hyde, M.M. Herman, S.E. Bachus, and G. Bali Reduced gap-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia Cereb Cortex 11 2001 136 147
31. S.M. Clinton, and J.H. Meador-Woodruff Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in schizophrenia and bipolar disorder Neuropsychopharmacology 29 2004 1353 1362
32. M.D. Fallin, V.K. Lasseter, D. Avramopoulos, K.K. Nicodemus, P.S. Wolyniec, and J.A. McGrath Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios Am J Hum Genet 77 2005 918 936
33. P.M. Thompson, C. Rosenberger, and C. Qualls CSF SNAP-25 in schizophrenia and bipolar illness A pilot study Neuropsychopharmacology 21 1999 717 722
34. C. Konradi, M. Eaton, M.L. MacDonald, J. Walsh, F.M. Benes, and S. Heckers Molecular evidence for mitochondrial dysfunction in bipolar disorder Arch Gen Psychiatry 61 2004 300 308
35. K. Aberg, P. Saetre, N. Jareborg, and E. Jazin Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia Proc Natl Acad Sci U S A 103 2006 7482 7487
36. N.R. Sibson, A. Dhankhar, G.F. Mason, D.L. Rothman, K.L. Behar, and R.G. Shulman Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity Proc Natl Acad Sci U S A 95 1998 316 321
37. K.L. Behar, and D.L. Rothman In vivo nuclear magnetic resonance studies of glutamate-gamma-aminobutyric acid-glutamine cycling in rodent and human cortex: The central role of glutamine J Nutr 131 2001 2498S 2504S
38. A.B. Patel, R.A. de Graaf, G.F. Mason, D.L. Rothman, R.G. Shulman, and K.L. Behar The contribution of GABA to glutamate/glutamine cycling and energy metabolism in the rat cortex in vivo Proc Natl Acad Sci U S A 102 2005 5588 5593
39. J.T. Coyle, G. Tsai, and D. Goff Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia Ann N Y Acad Sci 1003 2003 318 327
40. K. Hill, L. Mann, K.R. Laws, C.M. Stephenson, I. Nimmo-Smith, and P.J. McKenna Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies Acta Psychiatr Scand 110 2004 243 256
41. N.C. Andreasen, K. Rezai, R. Alliger, V.W. Swayze, M. Flaum, and P. Kirchner Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia Assessment with xenon 133 single-photon emission computed tomography and the tower of London Arch Gen Psychiatry 49 1992 943 958
42. P.J. Harrison, and D.R. Weinberger Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence Mol Psychiatry 10 2005 40 68
43. M.J. Owen, M.C. O'Donovan, and P.J. Harrison Schizophrenia: A genetic disorder of the synapse? BMJ 330 2005 158 159
44. K.P. Clancy, R. Berger, M. Cox, J. Bleskan, K.A. Walton, I. Hart, and D. Patterson Localization of the L-glutamine synthetase gene to chromosome 1q23 Genomics 38 1996 418 420
45. M. Beneyto, L.V. Kristiansen, A. Oni-Orisan, R.E. McCullumsmith, and J.H. Meador-Woodruff Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders Neuropsychopharmacology 32 2007 1888 1902
46. C.G. Lau, and R.S. Zukin NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders Nat Rev Neurosci 8 2007 413 426
47. J.T. Littleton, R.J. Barnard, S.A. Titus, J. Slind, E.R. Chapman, and B. Ganetzky SNARE-complex disassembly by NSF follows synaptic-vesicle fusion Proc Natl Acad Sci U S A 98 2001 12233 12238
48. J.T. Kittler, P. Rostaing, G. Schiavo, J.M. Fritschy, R. Olsen, A. Triller, and S.J. Moss The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors Mol Cell Neurosci 18 2001 13 25
49. P. Osten, S. Srivastava, G.J. Inman, F.S. Vilim, L. Khatri, and L.M. Lee The AMPA receptor GluR2 C terminus can mediate a reversible, ATP-dependent interaction with NSF and alpha- and beta-SNAPs Neuron 21 1998 99 110
50. D. Martins-de-Souza, W.F. Gattaz, A. Schmitt, G. Maccarrone, and E.Eberlin Hunyadi-Gulyas Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia J Psychiatr Res 11 2009 978 986
51. D. Martins-de-Souza, W.F. Gattaz, A. Schmitt, C. Rewerts, G. Maccarrone, and E. Dias-Neto Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia Eur Arch Psychiatry Clin Neurosci 3 2009 151 163
52. D. Martins-de-Souza, W.F. Gattaz, A. Schmitt, C. Rewerts, S. Marangoni, and J.C. Novello Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis J Neural Transm 116 2009 275 289
53. M. Nesvaderani, I. Matsumoto, and S. Sivagnanasundaram Anterior hippocampus in schizophrenia pathogenesis: Molecular evidence from a proteome study Aust N Z J Psychiatry 43 2009 310 322
54. C.M. Lewis, D.F. Levinson, L.H. Wise, L.E. DeLisi, R.E. Straub, and I. Hovatta Genome scan meta-analysis of schizophrenia and bipolar disorder Part II: Schizophrenia Am J Hum Genet 73 2003 34 48
55. P.A. Holmans, B. Riley, A.E. Pulver, M.J. Owen, D.B. Wildenauer, and P.V. Gejman Genomewide linkage scan of schizophrenia in a large multicenter pedigree sample using single nucleotide polymorphisms Mol Psychiatry 14 2009 786 795
56. M.Y. Ng, D.F. Levinson, S.V. Faraone, B.K. Suarez, L.E. DeLisi, and T. Arinami Meta-analysis of 32 genome-wide linkage studies of schizophrenia Mol Psychiatry 14 2009 774 785
57. H. Stefansson, D. Rujescu, S. Cichon, O.P. Pietilainen, A. Ingason, and S. Steinberg Large recurrent microdeletions associated with schizophrenia Nature 455 2008 232 236
58. International Schizophrenia Consortium Rare chromosomal deletions and duplications increase risk of schizophrenia Nature 455 2008 237 241
59. S.M. Clinton, V. Haroutunian, K.L. Davis, and J.H. Meador-Woodruff Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia Am J Psychiatry 160 2003 1100 1109
60. M. Beneyto, and J.H. Meador-Woodruff Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder Neuropsychopharmacology 33 2008 2175 2186
61. K.C. Murphy Schizophrenia and velo-cardio-facial syndrome Lancet 359 2002 426 430
62. T. Rietkerk, M.P. Boks, I.E. Sommer, J.S. de, R.S. Kahn, and R.A. Ophoff Network analysis of positional candidate genes of schizophrenia highlights myelin-related pathways Mol Psychiatry 14 2009 353 355
63. C. Zabel, A. Andreew, L. Mao, and D. Hartl Protein expression overlap: More important than which proteins change in expression? Expert Rev Proteomics 5 2008 187 205
64. J. Petrak, R. Ivanek, O. Toman, R. Cmejla, J. Cmejlova, D. Vyoral, J. Zivny, and C.D. Vulpe Deja vu in proteomics A hit parade of repeatedly identified differentially expressed proteins Proteomics 8 2008 1744 1749
65. R. Sultana, T. Reed, M. Perluigi, R. Coccia, W.M. Pierce, and D.A. Butterfield Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: A regional study J Cell Mol Med 11 2007 839 851
66. R. Sultana, D. Boyd-Kimball, J. Cai, W.M. Pierce, J.B. Klein, M. Merchant, and D.A. Butterfield Proteomics analysis of the Alzheimer's disease hippocampal proteome J Alzheimers Dis 11 2007 153 164
67. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, and R. Booze Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain Part II: Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate J Neurochem 82 2002 1524 1532
68. A. Castegna, M. Aksenov, M. Aksenova, V. Thongboonkerd, J.B. Klein, and W.M. Pierce Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 Free Radic Biol Med 33 2002 562 571
69. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease brain J Neurochem 85 2003 1394 1401
70. T. Tsuji, and S. Shimohama Analysis of the proteomic profiling of brain tissue in Alzheimer's disease Dis Markers 17 2001 247 257
71. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L. Faull, and G.J. Cooper Proteomic analysis of the brain in Alzheimer's disease: Molecular phenotype of a complex disease process Proteomics 1 2001 1519 1528
72. B. Balcz, L. Kirchner, N. Cairns, M. Fountoulakis, and G. Lubec Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's disease J Neural Transm 2001 193 201
73. T.T. Reed, W.M. Pierce Jr, D.M. Turner, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule J Cell Mol Med 13 2009 2019 2029
74. K. Kanninen, G. Goldsteins, S. Auriola, I. Alafuzoff, and J. Koistinaho Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach Neurosci Lett 367 2004 235 240
75. R. Vlkolinsky, N. Cairns, M. Fountoulakis, and G. Lubec Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease Neurobiol Aging 22 2001 547 553
76. S. Greber, G. Lubec, N. Cairns, and M. Fountoulakis Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease Electrophoresis 20 1999 928 934
77. M.A. Korolainen, S. Auriola, T.A. Nyman, I. Alafuzoff, and T. Pirttila Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain Neurobiol Dis 20 2005 858 870
78. S.H. Kim, R. Vlkolinsky, N. Cairns, M. Fountoulakis, and G. Lubec The reduction of NADH ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease Life Sci 68 2001 2741 2750
79. J. Choi, A.I. Levey, S.T. Weintraub, H.D. Rees, M. Gearing, L.S. Chin, and L. Li Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases J Biol Chem 279 2004 13256 13264
80. J. Choi, H.D. Rees, S.T. Weintraub, A.I. Levey, L.S. Chin, and L. Li Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases J Biol Chem 280 2005 11648 11655
81. P. Wang, F.G. Bouwman, and E.C. Mariman Generally detected proteins in comparative proteomicsa matter of cellular stress response? Proteomics 9 2009 2955 2966
82. E.C. Mariman 2DE-proteomics meta-data indicate the existence of distinct cellular stress-responsive mechanisms Expert Rev Proteomics 6 2009 337 339
83. K.O. Schubert, M. Focking, M.J. Dunn, and D.R. Cotter Proteomic analysis of the basic sub-proteome (pH 6-11) in the hippocampus in schizophrenia and bipolar affective disorder Schizophr Bull SIRS Abstracts Poster 169 2010 85
84. T.C. Lund, L.B. Anderson, V. McCullar, L. Higgins, G.H. Yun, and B. Grzywacz iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types J Proteome Res 6 2007 644 653
85. Y. Bai, K. Markham, F. Chen, R. Weerasekera, J. Watts, and P. Horne The in vivo brain interactome of the amyloid precursor protein Mol Cell Proteomics 7 2008 15 34
86. M. Basso, S. Giraudo, D. Corpillo, B. Bergamasco, L. Lopiano, and M. Fasano Proteome analysis of human substantia nigra in Parkinson's disease Proteomics 4 2004 3943 3952
87. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, and W.R. Markesbery Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 2001 373 383
88. D.A. Butterfield, A. Gnjec, H.F. Poon, A. Castegna, W.M. Pierce, J.B. Klein, and R.N. Martins Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment J Alzheimers Dis 10 2006 391 397
89. J.B. Leverenz, I. Umar, Q. Wang, T.J. Montine, P.J. McMillan, D.W. Tsuang, J. Jin, C. Pan, J. Shin, D. Zhu, and J. Zhang Proteomic identification of novel proteins in cortical lewy bodies Brain Pathol 17 2007 139 145
90. K. Krapfenbauer, E. Engidawork, N. Cairns, M. Fountoulakis, G. Lubec Aberrant Expression of peroxiredoxin subtypes in neurodegenerative disorders Brain Res 967 2003 152 160